Glen Burnie

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• Liver cirrhosis1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• 89bio, Inc.1 trial

Running trials

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  NCT06419374· Phase 3· Hoffmann-La Roche· Source

  Contact: 89bio Clinical Study Site

• Recruiting

  A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  NCT06318169· Phase 3· Hoffmann-La Roche· Source

  Contact: 89bio Clinical Study Site

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Liver cirrhosis1 recruiting

Closed trials

• Completed

  Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

  NCT04929483· Phase 2· 89bio, Inc.· Source